NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS

PENTAPEPTIDE AND METHODS OF USE THEREOF

Biomarkers for graft-versus-host disease

TARGETING P73 FOR CANCERS RESISTANT TO BH3 MIMETICS

INHIBITORS OF ENL/AF9 YEATS

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

EP300/CBP INHIBITOR

USE OF VIBEGRON TO TREAT OVERACTIVE BLADDER

HIV inhibitor compounds

Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors

Compositions and methods for treatment of pre-cancerous skin lesions

Inhibitors of Cancer Biomarkers and Uses Thereof

ASCAROSIDE TREATMENT OF EOSINOPHILIC ESOPHAGITIS

PYRIMIDOIMIDAZOLE COMPOUNDS USED AS DNA-PK INHIBITORS

Recombinant protein produced from cholinesterase gene derived from and the composition comprising the same for treating or preventing a neurological disease

Combinations of mRNAs encoding immune modulating polypeptides and uses thereof

Pharmaceutical compositions comprising meloxicam

Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

Target peptides for immunotherapy and diagnostics

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

Formulations comprising triptan compounds

Specific nutritional or therapeutic agent including a mixture of grape and blueberry

Compounds and compositions for treating conditions associated with NLRP activity

ANTI-CANCER COMPOSITIONS AND METHODS

2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS

Heteroaryl inhibitors of PDE4

BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER

Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

Preparation of Drug for Treating Alzheimer's Disease (AD)

DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE

CANCER TREATMENTS TARGETING CANCER STEM CELLS

COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR

TOPICAL COMPOSITION

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

USE OF GP73 INHIBITOR IN PREPARATION OF MEDICINE FOR TREATING DIABETES

GLP-1R MODULATING COMPOUNDS

AMNIOTIC FLUID FORMULATION FOR TREATMENT OF LUNG DISORDERS

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

GALACTOOLIGOSACCHARIDES FOR PREVENTING INJURY AND/OR PROMOTING HEALING OF THE GASTROINTESTINAL TRACT

COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION

HONOKIOL BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS

3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

NK CELL-BASED THERAPY

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING SAME

Compounds and methods for regulating, limiting, or inhibiting expression

Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases

Compositions and methods relating to inhibitors of pro-inflammatory factors for treatment of cancer

NOVEL COMPOUNDS AND FORMULATIONS

Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety

COMBINATION THERAPY USING FABP5 INHIBITORS WITH TAXANES FOR TREATMENT OF CANCER

Bacterial formulation

COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE DELIVERY OF VARIOUS AGENTS AND USE THEREOF

ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING ORAL MUCOSA AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF STOMATITIS USING SAME

Riluzole prodrugs and their use

Treatment method for colon cancer

Mitochondria-Targeted Atovaqone: A More Potent and More Effective Antitumor, Antimicrobial, and Antimalarial Drug

Cyclooxygenase-2 Inhibition for the Treatment of SAA-high Asthma

EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN

METHODS OF ADMINISTERING VOXELOTOR

METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS

PHTHALAZINONE DERIVATIVES

NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION

ULTRASONIC URINARY BLADDER DRUG DELIVERY

Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof

CANNABINOID AND OMEGA FATTY ACID COMPOSITIONS AND METHODS OF USING

TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING ONYCHOMYCOSIS

Antibacterial compounds

INGESTIBLE MEDICAL DELIVERY DEVICES

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

N,N--2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases

Toxicity Management for Anti-Tumor Activity of CARs

N2-ARYLMETHYL-4-HALOALKYL-PYRIDAZIN-3-ONE CFTR MODULATORS FOR THE TREATMENT OF CYSTIC FIBROSIS

MTOR-INHIBITOR-CONTAINING MEDICINE FOR TREATING OR PREVENTING OPHTHALMIC SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION THEREOF

IODINE COMPOUNDS FOR TREATING RESPIRATORY PATHOGENS

Compositions and uses of antimicrobial materials with tissue-compatible properties

COMPOUNDS FOR THE TREATMENT OF HIV

Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same

INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE

TRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Combination Therapy For Treatment Of Cancer

PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1

METHOD AND COMPOSITIONS FOR REGULATED ARMORING OF CELLS

SHP2 INHIBITORS AND USES THEREOF

METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES

PROTON ACTIVATED ATOMIC MEDICINE

HISTATIN-1 FORMULATION FOR THE TREATMENT, REPAIR OR REGENERATION OF BONE TISSUE IN A SUBJECT

A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP

Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure.

INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASE

Substituted pyrazoles showing serotonin 5-HT receptor activity

Method for producing a drug delivery system

SUSTAINED RELEASE OF ANTIINFECTIVES

Immuno-Oncolytic Therapies

FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE

ANTI-CD3 ANTIBODIES AND METHODS OF USE

TREATMENT OF THERAPY-RESISTANT HER-2 POSITIVE BREAST CANCER

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

Cellular fibronectin compositions

Inhibitors of peptidylarginine deiminases

Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents

TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS

Small molecule inhibitors targeting sporulation

AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS

Derivatives of resiquimod

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

METHODS AND COMPOSITIONS FOR INCREASING CIRCULATION DURING TREATMENT WITH ALTERNATING ELECTRIC FIELDS

Compositions and methods for increasing cancer cell sensitivity to alternating electric fields

METHOD OF TREATING CANCER BY ADMINISTRATION OF AN ANTI-PD-1 OR ANTI-PD-L1 THERAPEUTIC AGENT VIA A LYMPHATIC DEVLIERY DEVICE

NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS

COMPOSITIONS AND METHODS FOR TARGETING CELLULAR MOLECULES

CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE

Formulations and uses thereof

MNK INHIBITORS AND EIF4E PHOSPHORYLATION MODULATION TO TREAT INFLAMMATORY PAIN IN THE AGED

ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

Adjuvant treatment of HER2-positive breast cancer

NY-ESO-1-containing artificial adjuvant vector cell for use in treatment of cancer

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy

COMBINATION THERAPY WITH GLUCARPIDASE WITH METHOTREXATE/RITUXIMAB TO TREAT CNS LYMPHOMA

Processes for making a cellular fibronectin composition

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

Compositions and methods for treatment of GCase related disease states

TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION

COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES

COMBINATION THERAPY FOR TREATING COVID-19

PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORS

COMBINATION THERAPY FOR TREATING CANCER

GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS

METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

ALK2 inhibitors and methods for inhibiting BMP signaling

INTRANASAL DHE FOR THE TREATMENT OF HEADACHE

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

NOVEL USES OF CRENOLANIB

COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS

METHODS OF TREATING NASH

COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION

METHODS FOR TREATING INJURY ASSOCIATED WITH EXPOSURE TO AN ALKYLATING SPECIES

INHIBITORS OF HSP70 PROTEIN

COMPOSITIONS FOR DISRUPTING BIOFILM FORMATION AND FOR TREATING BIOFILM-RELATED DISORDERS

LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY

HIGH CONCENTRATION MEDICANT SOLUTIONS FOR TREATING NEUROLOGICAL DISORDERS

THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR CONTROLLED DRUG DELIVERY

COMPOUNDS AND METHODS OF PROMOTING MYELINATION

TREATMENT OF SKIN DISORDERS WITH TOPICAL COMPOSITIONS COMPRISING TAPINAROF AND A PDE4 INHIBITOR

NANOPARTICLES FOR MEDICAL AND DIAGNOSITC APPLICATIONS

GRANULES AND PREPARATION USING SAME

THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

ANTISENSE OLIGONUCLEOTIDE SEQUENCES FOR SILENCING THE HUMAN L1-MET TRANSCRIPT IN TUMORS

COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR 1 TARGETING

Antibodies that bind to OX40 and their uses

ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF

ANTIBODIES SPECIFIC TO GLYCOSYLATED CTLA-4 AND METHODS OF USE THEREOF

Bispecific PD-1 and TIGIT binding proteins and uses thereof

ANTI-SIGLEC-7 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODY AGAINST CLAUDIN 18A2 AND USE THEREOF

CD20 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE FOR IMMUNOTHERAPY

CD73 INHIBITORS

Glycosidase inhibitors

Inhibitors of Tryptophan Dioxygenases (IDO1 and TDO) And Their Use In Therapy

2-azaspiro[3.4]octane derivatives as M4 agonists

SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF

COMPOUNDS USEFUL IN HIV THERAPY

ERBB RECEPTOR INHIBITORS

CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS

Compounds and methods for treating cancer

NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES

PYRIMIDINEDIONE DERIVATIVES

SYSTEM AND MINIATURE DEVICES FOR DELIVERING A THERAPEUTIC COMPONENT TO A TREATMENT SITE IN A PATIENT

ANTIVIRAL THAT DESTROYS DNA AND/OR RNA OF VIRUSES AND VIROIDS

HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF

CODON OPTIMIZED NEW GENERATION REGULATABLE FUSOGENIC ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 VIRUS AND METHODS OF USE

MICROENCAPSULATION OF BACTERIOPHAGES AND RELATED PRODUCTS

Method for treating nociceptive pain and burns with brazilian green propolis alcohol extract

GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND USE THEREOF IN THE TREATMENT OF CANCER

ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO OVERCOME IMMUNOSUPPRESSION IN THE TUMOR MICROENVIRONMENT

METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES

MALTOSYL-ISOMALTO-OLIGOSACCHARIDES REDUCE SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE

BENZODIAZEPINE DERIVATIVES FOR TREATING A RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION

Substituted 5-fluoro-1H-pyrazolopyridines and their use

TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA

Crenolanib for treating FLT3 mutated proliferative disorders

Ophthalmic compositions

METHOD OF CONTROLLING BLOOD SUGAR LEVEL AND TREATMENT OF DIABETES AND RELATED CONDITIONS

METHODS OF TREATING BINGE EATING DISORDER

Treatment or Prevention of Ischaemic Stroke Reperfusion Injury

Method for making solid silica spheres

Compounds and compositions for intracellular delivery of therapeutic agents

BIOLOGICAL AGENT-EXOSOME COMPOSITIONS AND USES THEREOF

INFUSING DRUG SOLUTION DIRECTLY INTO BRAIN FLUID

Compositions comprising kakadu plum extract or acai berry extract

COMBINATION OF EXISTING DRUGS TO REPAIR THE ACTION POTENTIALS OF CELLS

ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE MARKERS ON LEUCOCYTES, AND USING THESE TO GUIDE ANTI-CLEVER-1 BASED CANCER TREATMENT

TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS

ANTI-DLL4/VEGF DUAL VARIABLE DOMAIN IMMMUNOGLOBULIN AND USES THEREOF

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

NOVEL ANTI-CD47 ANTIBODIES AND USES THEREOF

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

Compositions and methods for the treatment of immunodeficiency

Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereof

PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE

BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA

SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS

BCL-2 inhibitors

Salts, crystal forms, and production methods thereof

3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

(S)-N-HYDROXY-2-(2-(4-METHOXYPHENYL)BUTANAMIDO)THIAZOLE-5-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE

COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF

PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS

Compositions, Methods and Kits for Eliciting an Immune Response

INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS

Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity

TREATMENT OF DISEASES INVOLVING MUCIN

ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE AND ACID-FAST BACTERIA

ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION

ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITIS

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES

Chimeric antigen receptor-modified NK-92 cells

HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF

CARBAZATE-ACTIVATED POLYVINYL ALCOHOL (PVAC) AS A POLYMER-BASED ANTITUMORAL AGENT

USES OF NAD+ AND/OR NAD+ INHIBITORS AND/OR NAD+ AGONISTS AND COMBINATION PREPARATION THEREOF

Process for the synthesis of substituted chloromethyl dialkylphosphates

NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS

DOSING REGIMENS FOR A PROTEIN KINASE C INHIBITOR

MRGPRX2 ANTAGONIST FOR THE TREATMENT OF PSEUDO ALLERGIC REACTIONS

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VASOMOTOR SYMPTOMS

Azalactam compounds as HPK1 inhibitors

APREMILAST LOW-DOSE TOPICAL PHARMACEUTICAL COMPOSITIONS

METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS

Creatine, its derivatives, compositions and methods of use thereof

MUCOADHESIVE COMPOSITIONS AND METHOD OF USE THEREOF

Cannabidiol and/or Cobicistat Combination Drug Therapy

Starch-free soft chew for veterinary applications

ANTI-FRUCTOSE THERAPY FOR COLORECTAL AND SMALL INTESTINE CANCERS

METHOD FOR HYDRATING WATER-INSOLUBLE POLYMER CAPABLE OF CONTAINING INTERMEDIATE WATER

BENZOXABOROLE POLYMERS AND METHODS OF USE

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS

ANTI-PSGL-1 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFALMMATORY PHENOTYPES AND USES THEREOF

Heme sequesting peptides and uses therefor

THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

NOVEL SUBSTITUTED 1,3-8-TRIAZASPIRO[4,5] DECANE-2,4-DIONE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN 2,3-DIOXYGENASE (TDO) INHIBITORS

Pyrimidine compound as JAK kinase inhibitor

Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA

Prodrugs of riluzole and their method of use

THERAPEUTIC ANNEXIN-DRUG CONJUGATES AND METHODS OF USE

Modulators of BCL6 proteolysis and associated methods of use

COMBINATION THERAPY WITH PROTEIN KINASE B ACTIVATION INHIBITOR TO TREAT CANCER

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

LAG3 binding peptides

CXCR4 ANTAGONIST PEPTIDES

TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS

FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE

Methods for treating pulmonary non-tuberculous mycobacterial infections

Methods of Use of Glucosamine for Increasing Nitrogen Retention

MICROBIOME REGULATORS AND RELATED USES THEREOF

COMPOUNDS

A PYRAZOLOPYRIMIDINE DERIVATIVE AS A HCK INHIBITOR FOR USE IN THERAPY, IN PARTICULAR MYD88 MUTATED DISEASES

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

Pyruvate kinase activators for use in treating blood disorders

THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE

METHODS FOR MODIFYING ENDOPLASMIC RETICULUM PROCESSING OF PROTEIN

Use of cannabinoids in the treatment of epilepsy

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

THERAPEUTIC PROTEIN-BASED NANOPARTICLES AND METHODS FOR MAKING THE SAME

Compositions and methods for the treatment and prophylaxis of surgical site infections

NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO

Anti-fungals compounds targeting the synthesis of fungal sphingolipids

SMALL EXTRACELLULAR VESICLE-ASSOCIATED VEGF AS A PREDICTOR FOR THERAPEUTIC RESPONSES

BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION

COMPOSITIONS FOR PATIENT SPECIFIC IMMUNOTHERAPY

SYSTEMS AND METHODS FOR INTEGRATED ANALYSIS OF BLOOD AND SURGICAL DRAIN FLUID BIOMARKERS

METHODS OF USING FLT3L-Fc FUSION PROTEINS

Methods of Treating Cancer with an Anti-CD39 Antibody

TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

ANTI-EPHA10 ANTIBODIES AND METHODS OF USE THEREOF

Anti-NKG2A antibodies and compositions

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS INVOLVING CHIMERIC BINDING POLYPEPTIDES

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE

COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC BIOLOGICS FOR TREATMENT OF DISEASE

PROTEIN-BASED BIOMATERIAL WITH VISCOELASTIC BEHAVIOUR, PROCESS FOR OBTAINING IT AND USES THEREOF

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

ALLOGENEIC CELL COMPOSITIONS AND METHODS OF USE

Long-lasting GLP1 analogue drug for type-2 diabetes

Compositions and methods for treating SARS-CoV-2 infections

HPK1 INHIBITORS AND USES THEREOF

BORON-CONTAINING RHO KINASE INHIBITORS

COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF